A recent study reaffirmed the safety and effectiveness of guselkumab, in managing psoriasis and psoriatic arthritis over an extended period of 208 weeks (approximately 4 years). This ...
The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.